In the Foye household in Pine Brook, N.J., a biomedical twist on an Advent calendar went up on the fireplace mantle in early October: a countdown to the day they would find out what gene caused 11-year-old Adam Foye’s muscle-weakening disease. Scientists from around the world had combed through the DNA blueprints of Adam and his parents as part of a contest intended to provide new thinking on dealing with many of the problems that come with new sequencing technologies.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help